Superior Oral Bioavailability of Epigallocatechin Gallate from TèPigal 300®, a Dietary Supplement Versus a Cup of Green Tea
Journal Title: Journal of Clinical Medical Research - Year 2025, Vol 6, Issue 1
Abstract
Background: Epigallocatechin Gallate (EGCG), a potent compound found in green tea, is renowned for its multifaceted health benefits. Unfortunately, despite its therapeutic potential, the bioavailability of EGCG remains a challenge and differences in bioavailability by mode of administration significantly influence its therapeutic efficacy. Oral intake of EGCG often results in low absorption due to factors such as first-pass metabolism and limited intestinal permeability. Our study focuses on TèPigal 300®, a product containing 300 mg of EGCG, comparing its plasma concentration profile to that of green tea. Methods and Findings: Through in-vitro dissolution studies, we observed a significant release of EGCG in alkaline pH conditions, closely mimicking the intestinal absorption environment, supporting the effectiveness of the tablet formulation in enhancing EGCG absorption. The clinical aspect of our research involved a study of 22 healthy subjects to evaluate the relative bioavailability of EGCG, based on plasma concentration profiles (AUC) of EGCG from one tablet of TèPigal 300® in comparison with the consumption of one cup of green tea. Notably, in 10 healthy subjects EGCG was detectable in the bloodstream within 15 minutes, with increasing levels up to 60 minutes. This pattern suggests efficient absorption following EGCG release. Further comparison with the consumption of 1 cup of green tea in 12 healthy subjects highlighted the superior oral bioavailability of EGCG from TèPigal 300® tablets over tea beverage intake, quantifying this difference as one TèPigal 300® tablet being equivalent to consuming 21 cups of green tea. Conclusion: our study underlines TèPigal 300® advantage in providing a more efficient convenient form of EGCG consumption, leading to potentially greater health benefits. Our promising results open avenues for future research on improving EGCG bioavailability through new technologies and nutrients synergies.
Authors and Affiliations
Felicia Vista1, Mariangela De Carolis1, Daniele De Filippis1, Massimiliano Romiti1, Anna Angela Barba2, Massimo Bonucci3,4*
Keywords
Related Articles
- EP ID EP765010
- DOI https://doi.org/10.46889/JCMR.2025.6111
- Views 13
- Downloads 0
OneHealth Applications of Low Level Laser Therapy
Advances in human medicine have long been founded on the initial research conducted with animals. New products and innovative treatment options that are successful in pre-clinical rodent, canine and/or nonhuman primate...
Integrating Artificial Intelligence and Neural Networks for Enhanced Diagnosis of Atopic Dermatitis
Introduction: Atopic dermatitis, a chronic inflammatory skin condition, disproportionately affects young children. Statistics show that up to 90% of cases are diagnosed before the age of five. Despite its prevalence, the...
Clinical Guideline for Zirconia Dental Implants: A Comprehensive and Critical Review and Update
Zirconia implants have become a very promising alternative to conventional titanium implants for oral rehabilitation with superior biological and esthetical properties. An electronic search through PubMed about zirconia...
Incremental Increases in Non-Exercise Estimated Fitness Reduce Subsequent Depressive Symptoms
The purpose of this observational retrospective cohort study was to examine the association between non-exercise estimated Cardiorespiratory Fitness (eCRF) and incident depressive symptoms. A total of 14,431 participants...
Osmolality Threshold for Sickle Cell Erythrocyte Hemolysis
Background: The importance of fluid intake is well document as metabolic and physiological processes operate effectively in a homeostatic environment. Normal red cells are more resilient to changes in serum osmolality...